确定撒哈拉以南非洲多个国家的老年人脆弱指数值
Gideon Dzando1, Paul R Ward2, Lillian Mwanri2
1Research Centre for Public Health, Equity and Human Flourishing, Torrens University Australia, Wakefield Campus, Adelaide, Australia. Gideon.Dzando@torrens.edu.au.
Communications medicine
|June 17, 2025
概括
这项研究使用特定国家的数据为撒哈拉以南非洲 (SSA) 的老年人制定了新的脆弱值. 这些发现使得该地区的脆弱性查和文化相关干预措施更准确.
科学领域:
- 老年学是一门学科.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 在撒哈拉以南非洲 (SSA) 的脆弱性查通常使用为高收入国家开发的工具和门,这可能不合适.
- 在SSA的上下文差异需要开发特定区域的脆弱性评估工具和值.
研究的目的:
- 为撒哈拉以南非洲地区的老年人制定一个特定环境的脆弱指数值.
- 提高SSA地区脆弱性查的准确性和文化相关性.
主要方法:
- 分析了来自四个SAS国家 (肯尼亚,加纳,乌干达,科特迪瓦) 的5527名年龄在50岁以上的个体的综合横截面数据.
- 特定国家的脆弱性值是使用接收器操作特征 (ROC) 分析来确定的.
- 通过随机效应元分析建立了一个单一的,聚合的脆弱值.
主要成果:
- ROC分析显示了高准确度,曲线下的面积在0.91到0.94.9之间.
- 敏感度从0.83到0.94不等,特异性从0.72到0.87.
- 从聚合分析中得出0.29 (95% CI:0.25,0.33) 的整体脆弱性值.
结论:
- 使用SSA的特定背景数据开发脆弱性值为文化相关干预提供了有价值的见解.
- 有效的脆弱性查需要考虑人口层面的人口,健康和社会文化差异.
- 这项研究为SSA中老年人建立了更合适的脆弱值,提高了查准确度.
相关概念视频
The Effect of Aging on Tissues
3.6K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.6K
Drug Dosing: Geriatric Patients
395
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
395
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
861
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
861
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
382
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
382
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
354
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
354
Pharmacodynamics in Geriatric Patients: Effects of Age
367
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
367


